Dr Weber on the Background of the KEYNOTE-942 Trial in High-

Jeffrey S. Weber, MD, PhD, discusses the background for the KEYNOTE-942 trial, which was conducted in resected high-risk melanoma.

Related Keywords

Jeffreys Weber , , Grossman School Of Medicine , Melanoma Research Program , Langone Perlmutter Cancer Center , York University , New York University , Isaac Perlmutter Professor , Nyu Langone X27s Perlmutter Cancer Center , Onclive Tv , Melanoma , Skin Cancer ,